Accounts payable and accrued expenses consist of the following:


	March 31,		December 31,
(In thousands)	2026		2025
Accounts payable	$	102,357	$	107,950
Accrued compensation		53,430		82,450
Accrued other		136,792		99,165
Total accounts payable and accrued expenses	$	292,579	$	289,565

A summary of the Company’s current provision for sales discounts, allowances and reserves was as follows:


	March 31,		December 31,
(In thousands)	2026		2025
Medicaid rebates	$	189,032	$	186,068
Product discounts		18,700		18,688
Medicare Part D		25,487		25,372
Other		39,624		16,998
Total accrued sales discounts, allowances and reserves	$	272,843	$	247,126

Included in accounts payable was approximately $38.6 million and $59.6 million of amounts payable related to state U.S. Medicaid rebates as of March 31, 2026 and December 31, 2025, respectively.